nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.00117	0.237	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.00114	0.232	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.00113	0.228	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.00089	0.18	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.00061	0.124	CrCbGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00038	0.000382	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00038	0.000381	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000379	0.000381	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00037	0.000372	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000363	0.000365	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000363	0.000365	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00036	0.000362	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00036	0.000361	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000359	0.00036	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000358	0.00036	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000358	0.00036	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000356	0.000358	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000355	0.000357	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000354	0.000356	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000354	0.000356	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000354	0.000355	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000353	0.000355	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000353	0.000355	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000352	0.000354	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000352	0.000354	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000352	0.000354	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000351	0.000353	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000351	0.000353	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000351	0.000353	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00035	0.000352	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00035	0.000352	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00035	0.000351	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000349	0.000351	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000348	0.00035	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000348	0.000349	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000347	0.000349	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000346	0.000348	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000346	0.000348	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000345	0.000347	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000344	0.000346	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000343	0.000345	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000342	0.000344	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00034	0.000341	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000337	0.000339	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000332	0.000333	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00033	0.000332	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000327	0.000329	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000327	0.000328	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000326	0.000327	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000325	0.000327	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000323	0.000325	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000323	0.000325	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000322	0.000323	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000321	0.000323	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000321	0.000323	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000321	0.000322	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000321	0.000322	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00032	0.000321	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00032	0.000321	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000319	0.000321	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000319	0.00032	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000315	0.000317	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000315	0.000316	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000314	0.000316	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000313	0.000315	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000311	0.000312	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00031	0.000312	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000308	0.000309	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000304	0.000306	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000304	0.000305	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000304	0.000305	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000302	0.000304	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.0003	0.000301	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000299	0.000301	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000299	0.0003	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000297	0.000299	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	0.000297	0.000299	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000297	0.000298	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000296	0.000297	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000295	0.000296	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000295	0.000296	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000295	0.000296	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000295	0.000296	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000294	0.000296	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000293	0.000295	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000292	0.000294	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000292	0.000294	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00029	0.000291	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000289	0.00029	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000284	0.000285	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000283	0.000284	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00028	0.000281	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000279	0.00028	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000279	0.00028	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000274	0.000276	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000274	0.000275	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00027	0.000271	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000269	0.00027	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000268	0.00027	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000268	0.00027	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000268	0.000269	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000267	0.000269	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000266	0.000267	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000265	0.000266	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000264	0.000265	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000263	0.000265	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000263	0.000264	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000262	0.000264	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000259	0.00026	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000258	0.000259	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000256	0.000257	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000256	0.000257	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000255	0.000257	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000255	0.000257	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	0.000254	0.000256	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000252	0.000253	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000252	0.000253	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000252	0.000253	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000252	0.000253	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000249	0.00025	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000248	0.000249	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000247	0.000248	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000245	0.000247	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000245	0.000246	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000242	0.000243	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000241	0.000243	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000236	0.000237	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000235	0.000237	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000233	0.000234	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000233	0.000234	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000232	0.000234	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000232	0.000233	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000229	0.00023	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000228	0.000229	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000228	0.000229	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000227	0.000229	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000227	0.000228	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000227	0.000228	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000226	0.000228	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000225	0.000227	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000225	0.000226	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000225	0.000226	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000224	0.000225	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000222	0.000223	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000222	0.000223	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000221	0.000222	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000221	0.000222	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00022	0.000221	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000219	0.00022	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000218	0.000219	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000218	0.000219	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000218	0.000219	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000217	0.000218	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000215	0.000216	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000214	0.000215	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000213	0.000214	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00021	0.000211	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00021	0.000211	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00021	0.000211	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000209	0.00021	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000209	0.00021	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000209	0.00021	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000208	0.000209	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000208	0.000209	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000207	0.000208	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000206	0.000207	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000206	0.000207	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000206	0.000207	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000202	0.000203	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000202	0.000203	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000196	0.000197	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000196	0.000197	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000196	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	0.000195	0.000196	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000194	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000194	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000193	0.000194	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000193	0.000194	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000192	0.000193	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000191	0.000192	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00019	0.000191	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	0.00019	0.000191	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000189	0.00019	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000189	0.00019	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000188	0.000189	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000187	0.000188	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000186	0.000187	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000186	0.000187	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000178	0.000179	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000177	0.000178	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000175	0.000176	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000175	0.000176	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000175	0.000176	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000174	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000174	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000173	0.000174	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000173	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000172	0.000173	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000172	0.000173	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000168	0.000169	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000167	0.000168	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000165	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000163	0.000164	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000161	0.000162	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00016	0.00016	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000158	0.000159	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000158	0.000159	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	0.000157	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00015	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000148	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000148	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000148	0.000149	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000146	0.000147	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000146	0.000146	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000146	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000145	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000145	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000143	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000143	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000138	0.000138	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000136	0.000137	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	0.000135	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000134	0.000135	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000133	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000133	0.000133	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00013	0.000131	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000129	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000125	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000124	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000123	0.000124	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000122	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000122	0.000123	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000114	0.000115	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000114	0.000114	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000112	0.000112	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000112	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000111	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000111	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00011	0.000111	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00011	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000109	0.00011	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000106	0.000107	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	0.000103	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000103	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000102	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000102	0.000102	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.36e-05	9.41e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.21e-05	9.26e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.19e-05	9.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.16e-05	9.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.13e-05	9.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.05e-05	9.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.02e-05	9.07e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	8.75e-05	8.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.38e-05	8.42e-05	CbGpPWpGaD
